Tisotumab vedotin - Genmab/Seagen
At a glance
- Drug Originator Genmab
- Drug Licenced by Seagen; ZAI Lab
- Drug Class Antineoplastics; Auristatins; Drug conjugates; Immunotherapies; Immunotoxins; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Mitosis inhibitors; Tubulin polymerisation inhibitors
- USA Patent Applicants SEAGEN
- USA Patents 1
- BLAs 1
Table of Contents

Disclaimer